Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Cancer will cost the world $25 trillion over next 30 years

<< Previous

Bullboard Posts

Next >>

Comment by Kswdeluxon Mar 14, 2023 11:51am

173 Views

Post# 35337463

RE:RE:RE:RE:RE:Cancer will cost the world $25 trillion over next 30 years

I had posted this back in Dec, 2022, but will repost and add to it...
I was concerned about this a few years back and queried MM at that time. His response was basically as follows... ( not his words... but my recap of...)

In order for someone to attempt a hostile take over, they would have to buy up at least 10% of the float to even begin to push the issue. More likely 15-20% to be successful on a hostile take over.

At the daily volumes we are experiencing at this time it would take well over a month to buy up that much stock, more like 3 or 4 months, and accumulating a minimum of 10% of the float and would significantly drive up the stock price. Buying up 16%-20% would drive the SP uo even higher.

If they were a corporation, that corporation would have to disclose to its share holders within 28 days that they were buying ONC. So their buying would be exposed within 28 day. Once the market and shareholders found that BP was buying heavily into ONC that would drive up the price even more.

Once they buy more than 10% they become a major share holder. Once they own more than 10%, and then have to report all buying and selling, until they are less than 10% again.

If they did manage to collect 10%, 15% or 20% or more over 3-4 months and tried to push the issue, ONC would go to the SEC and request a 3rd party fair market evaluation of ONC and that information would then be published to ONC shareholders, and as of that NR the new trading SP would jump to the determined 3rd party market evaluation.

That 3rd party evaluation will be in depth and take into consideration both registration studies, fast track designation, IND and CAR T, etc... and the value of revenues after such approvals. MM was not concerned about a hostile take over.

A hostile take over will not happen at theses prices.

Based on that response, IMO ONC feels the real SP of ONC is well above current trading prices, and that wac4-5 years ago now, but draw your own conclusions.

Hope that helps.